Business Insights and Analytics

Our Insight team applies rigorous analysis and expert interpretation in order to provide strategic recommendations

Read more

Strategic and Scientific Consulting

Our Consulting team help solve complex scientific and commercial challenges throughout the product lifecycle

Read more

Scientific and Creative Communications

Our Communications team care passionately about the science and making evidence matter across the entire healthcare spectrum

Read more

Business Insights and Analytics

Plus icon

Our Insight team applies rigorous analysis and expert interpretation in order to provide strategic recommendations

Read more

Strategic and Scientific Consulting

Plus icon

Our Consulting team help solve complex scientific and commercial challenges throughout the product lifecycle

Read more

Scientific and Creative Communications

Plus icon

Our Communications team care passionately about the science and making evidence matter across the entire healthcare spectrum

Read more

Why we do what we do

The healthcare industry is going through fundamental change and in this uncertainty our clients need to convert great science into winning strategy

Our clients tell us they need our support in making the right strategic decisions that ensure their products fulfil their potential and ultimately improve people’s lives

We love working at the cutting edge, helping to tackle our clients’ newest and most complex problems

Teams of experts

We are expert navigators helping guide our clients to more successful outcomes

Our people

With a global perspective

We work with 24 of the top 25 pharmaceutical companies as well as 100s of biotechs globally from our offices in the US and Europe

Contact us

Solving unique problems

Whether we are supporting you on your journey, or delivering specialist expertise, we are helping you make important choices

How we work

Share our fresh thinking >

Faster new drug approvals, but at what cost?
Faster new drug approvals, but at what cost?
In 2018, the industry saw a record breaking 56 new drug approvals by the FDA. While 2019 is lagging behind with only 20 approvals, the Director of the FDA’s Center for Drug Evaluation and Research, Janet Woodcock, M.
Every breath you take
Every breath you take
It's difficult not to be excited by the potential of breath-activated cancer diagnosis as published widely in the UK media this week.
Are you following new conference guidelines for abstracts, posters and oral presentations?
Are you following new conference guidelines for abstracts, posters and oral presentations?
Data transparency and publication ethics have been hot topics in healthcare for as long as I care to remember, but until now this has been difficult to translate to publications in a conference setting.
Why can't we all just get along? Calls for greater collaboration between the NHS and the life sciences industry
Why can't we all just get along? Calls for greater collaboration between the NHS and the life sciences industry
While the NHS and academia have long-standing relationships, commonly working together to investigate the use of innovative medical and surgical therapies, the NHS' relationship with the life sciences industry is a slightly more strained one.

Let’s work together

The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today

Contact us